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in Australia (5). Given the afore-
mentioned linguistic and coordina-
tion issues with follow-up of migrant 
workers and the potential gravity of 
inappropriate clinical follow-up, it 
may be prudent to consider Q fever 
vaccination for all employees who 
work within UK meat-processing in-
dustries.
Public health practitioners should 
be aware of the continuously evolv-
ing multinational makeup of the local 
population and this should stimulate 
constant review of local translation 
services because census data seriously 
underrecognize the ethnic minority 
migrant worker population. Further-
more, many migrant workers are un-
sure of their rights to access primary 
and hospital care and the structure 
of healthcare is unfamiliar to many. 
GPs should consider zoonotic infec-
tions, such as Q fever, when patients 
with acute febrile illness report oc-
cupational livestock exposure, espe-
cially because migrant workers have 
become an important source of labor 
(sometimes preferred over domestic 
workers) in the agricultural workforce 
in the United Kingdom (2).
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Fatal Streptococcus 
equi subsp. 
ruminatorum 
Infection in a Man
To the Editor:  Streptococcus 
equi belongs to the pyogenic group 
of streptococci and to group C of the 
Lanceﬁ  eld classiﬁ  cation. It consists of 
3 subspecies of zoonotic agents rarely 
reported as human pathogens (1,2): S. 
equi subsp. equi, S. equi subsp. zooep-
idemicus, and S. equi subsp. ruminato-
rum. We report here a case of human 
infection caused by S. equi subsp. ru-
minatorum. (3).
A 53-year-old man was admitted 
to an intensive care unit of our hospital 
(University Teaching Hospital, Mont-
pellier, France) on April 28, 2006, 
with a high fever and in a comatose 
state. The day before, he had experi-
enced headache and neck pain. He had 
been infected with HIV for 9 years but 
had not had an opportunistic infection. 
His ongoing HIV treatment consisted 
of ritonavir, lopinavir, abacavir, lami-
vudine, and co-trimoxazole; 3 weeks 
before admission, his blood CD4+ T-
cell count was 133/μL, and viral load 
was 118,000 copies/mL. At the time of 
admission, his body temperature was 
38.9°C, heart rate was 105 beats/min, 
and blood pressure was 55/35 mmHg. 
He exhibited a ﬁ  xed pupil in 1 eye, 
neck stiffness, and was nonresponsive. 
He had bilateral pulmonary inﬁ  ltrates 
and severe hypoxemia. Treatment con-
sisted of mechanical ventilation, ﬂ  uid 
therapy, and norepinephrine. Labora-
tory investigations found the follow-
ing: leukocyte count 9,600/mm3 with 
90% neutrophils, hemoglobin level 9.0 
g/dL, platelet count 32,000/mm3, C-
reactive protein value 159 mg/L, and 
blood lactate concentration 3.2 mmol/
L. Computed tomographic scanning 
of the brain showed no hemorrhage 
or edema. Lumbar puncture produced 
turbid cerebrospinal ﬂ  uid (CSF) with 
300 leukocytes/mm3 (95% neutro-
phils), protein 5.6 g/L, glucose <0.1 
mmol/L, and gram-positive cocci. 
Three sets of aerobic-anaerobic blood 
cultures and bronchial aspirates were 
sampled, and intravenous treatment 
with dexamethasone (10 mg/6 h/day), 
cefotaxime (2 g/4 h/day), and vanco-
mycin (30 mg/kg/day) was initiated. 
On day 2, the hemodynamic state was 
stabilized, but brain death occurred.
All sets of aero-anaerobic blood 
cultures, CSF, and bronchial aspirate 
ﬂ  uid yielded the growth of a catalase-
negative,  β-hemolytic, gram-positive 
cocci belonging to the Lanceﬁ  eld 
group C of streptococci. Antimicrobi-
al susceptibility testing showed a bac-
terium fully susceptible to antibiotics 
tested. MICs of penicillin, amoxicil-
lin, and cefotaxime were 0.047, 0.125, 
and 0.125 mg/L, respectively. The 
isolates were identiﬁ  ed as S. equi by 
using the Vitek2 system, rapid ID32 
STREP, and API 20 STREP strips 
(bioMérieux, Marcy l’Etoile, France), 
but phenotype was inconclusive for 
subspecies identiﬁ  cation. The strains 
were identiﬁ  ed  as  S. equi subsp. 
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zooepidemicus by Vitek2, but aescu-
lin was not hydrolyzed, and D-ribose 
fermentation was noted, as previously 
described for S. equi subsp. rumina-
torum. 16S rRNA gene–based identi-
ﬁ  cation was performed as previously 
described (4) on strain ADV 6048.06 
from blood. The 1,396-bp sequence 
(GenBank accession no. EF362949) 
was compared with databases by using 
the BLAST program (5); the sequence 
differed by only 1 nucleotide posi-
tion (>99.9% identity) from the se-
quence of S. equi subsp. ruminatorum 
CECT 5772T. Other primarily related 
sequences were from S. equi subsp. 
ruminatorum strains of animal origin 
(99.5%–99.9% identity) and from S. 
equi subsp. zooepidemicus, (98.7% 
identity). Phylogenetic trees clustered 
the clinical isolate with S. equi subsp. 
ruminatorum strains to form a robust 
lineage, well separated from other 
strains of S. equi and supported by a 
high bootstrap value (Figure).
S. equi subsp. equi and S. equi 
subsp.  zooepidemicus are zoonotic 
agents implicated in diverse animal in-
fections such as strangles, mastitis, ab-
scesses, wounds, and respiratory and 
uterine infections. Human infections 
caused by S. equi subsp. equi, and S. 
equi subsp. zooepidemicus includ-
ed outbreaks of foodborne diseases 
(6,7), meningitis, septicemia, arthritis, 
pneumonia, glomerulonephritis, and 
streptococcal toxic shock syndrome, 
in both immunocompromised and 
immunocompetent patients (1,2,8,9). 
S. equi subsp. ruminatorum was de-
scribed in 2004 in domestic sheep and 
goats with mastitis (3). More recently, 
it was isolated during severe infec-
tions in spotted hyenas and zebras 
(10). No human isolate has been re-
ported to date. Moreover, none of the 
3 subspecies of S. equi has been iso-
lated from HIV-infected patients. The 
current case underlines the conclusion 
that molecular identiﬁ  cation of S. equi 
subsp.  ruminatorum  is essential. S. 
equi subsp. ruminatorum could have 
been underestimated due to its poten-
tial misidentiﬁ  cation as S. equi subsp. 
zooepidemicus by phenotypic tools. 
Despite the rare occurrence of group 
C streptococci in human infections, a 
high death rate is reported for invasive 
infections (7–9). S. equi subsp. zooep-
idemicus produce superantigen exo-
toxin that may have been implicated in 
the pathogenesis of fatal infection (2); 
S. equi subsp. ruminatorum should 
also be investigated for potential viru-
lence factors for humans.
Epidemiologic investigations were 
unsuccessful in tracing the patient’s in-
fection to an animal source. The respi-
ratory tract, from which S. equi subsp. 
ruminatorum was recovered in pure 
culture, could be considered the most 
probable portal of entry.
The mode of S. equi subsp. ru-
minatorum transmission to humans 
remains unknown. More information 
is needed on its reservoirs, but they 
likely resemble those of S. equi subsp. 
equi, and S. equi subsp. zooepidemicus 
(2,6,7). Prevention of human infections 
due to S. equi should include frequent 
microbiologic sampling of lactating 
animals and control measures for un-
pasteurized dairy products (7). Better 
characterization of underlying condi-
tions that increase risk of invasive S. 
equi infections is also needed. This 
knowledge could help deﬁ  ne high-risk 
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Figure. Neighbor-joining tree showing the phylogenetic placement of strain ADV 6048.06 
(boldface) among members of the Streptococcus equi species in the pyogenic group 
of streptococci. Twenty-three 16S rRNA gene sequences selected from the GenBank 
database were aligned with that of strain ADV 6048.06 by using ClustalX 1.83 (available 
from http://bips.u-strasbg.fr/fr/documentation/ClustalX). Alignment of 1,263 bp was used 
to reconstruct phylogenies by using PHYLIP v3.66 package (http://evolution.genetics.
washington.edu/phylip.html). The neighbor-joining tree was constructed with a distance 
matrix calculated with F84 model. Numbers given at the nodes are bootstrap values 
estimated with 100 replicates. S. pneumoniae is used as outgroup organism. Accession 
numbers are indicated in brackets. The scale bar indicates 0.005 substitutions per 
nucleotide position. Maximum likelihood and parsimony trees were globally congruent with 
the distance tree and conﬁ  rmed the placement of the strain ADV 6048.06 in the S. equi 
subspecies ruminatorum (SER) lineage. SEZ, S. equi subspecies zooepidemicus. LETTERS
groups of persons and could lead to 
generation of speciﬁ  c preventive rec-
ommendations.
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Rabies Prophylaxis 
for Pregnant 
Women
To the Editor: Rabies poses a 
100% risk for death to pregnant wom-
en and an indeterminate risk to the 
fetus (1,2). Although a theoretical risk 
exists for adverse effects from rabies 
immune globulin and killed rabies vi-
rus vaccines, several studies assessing 
the safety of this treatment have failed 
to identify these risks (3–6). Indeed, 
the consensus is that pregnancy is not 
a contraindication to rabies postexpo-
sure prophylaxis (PEP) (7). Despite 
this concensus, healthcare providers 
resist treating pregnant women with 
rabies PEP. We describe a case of a 
pregnant woman with uncertain rabies 
exposure.
A 35-year-old pregnant woman 
(at 34 weeks gestation) sought treat-
ment 3 weeks after being exposed to 
a bat. The patient reported awakening 
at 3:00 AM to ﬁ  nd a bat ﬂ  ying in her 
bedroom. She attempted to conﬁ  ne 
the bat to 1 section of the home and 
then called for help. A relative trapped 
and retrieved the bat, then disposed of 
the animal without further incident. 
The patient denied being bitten by 
the bat, and she had no obvious bite 
marks after the event. Initially, the 
patient sought information from on-
line resources, her primary care phy-
sician, and her obstetrician. She was 
uncertain whether rabies PEP was 
warranted, given what she believed to 
be the low probability of the bat be-
ing rabid and the low likelihood of her 
having had direct exposure to the bat. 
The patient did express concern about 
the safety of rabies PEP in pregnant 
women. Because no unequivocal rec-
ommendations were made by either 
her primary care physician or obstetri-
cian, she sought further advice from 
the Infectious Diseases Department 
at the University of Michigan on how 
best to proceed.
The 1999 recommendations of 
Centers for Disease Control and Pre-
vention Advisory Committee on Im-
munization Practices state, “... postex-
posure prophylaxis can be considered 
for persons who were in the same 
room as the bat and who might be un-
aware that a bite or direct contact had 
occurred ...” (8). Bat bites may not be 
apparent when they occur, even with 
careful examination. In fact, most of 
the recent human rabies patients have 
no known history of exposure to a ra-
bid animal (9,10). Of the 21 cases of 
bat-associated rabies in the United 
States during 1980–1999, 12 (57%) 
occurred in persons with apparent bat 
contact but no detectable bites (8). 
Our patient woke up with a bat ﬂ  y-
ing in her room and did not know how 
long it had been there. The best course 
of action would have been to test the 
bat for rabies. However, because the 
animal had already been disposed of, 
laboratory testing for rabies was not 
possible. Furthermore, given that 5%–
9% of bats tested in Washtenaw Coun-
ty, Michigan, are positive for rabies 
(www.mdch.state.mi.us/pha/epi/cded/
cd/batcoframe.htm), the exposure risk 
was not insigniﬁ  cant.  Therefore,  it 
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